Shinzo Kudoh, MD | Authors

New York University

360 ESSEX ST STE 201


Irinotecan in Small-Cell Lung Cancer-Japanese Trials

July 02, 2000

Irinotecan has appeared to have significant activity against previously treated and untreated small-cell lung cancer (SCLC). The major toxicities of irinotecan are neutropenia and diarrhea, although there is interpatient